Literature DB >> 8600038

The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature.

P A Drew1, W M Murphy, F Civantos, V O Speights.   

Abstract

Clear cell adenocarcinoma of the lower urinary tract is a rare neoplasm whose histogenesis has not been thoroughly investigated. We have examined six specimens of clear cell adenocarcinomas collected from three institutions using histological, histochemical, and immunohistochemical techniques. Results indicate that almost all clear cell adenocarcinomas of this region express morphological and antigenic features, suggesting müllerian differentiation, and that müllerian differentiation is not a feature of either nonclear cell adenocarcinomas or normal female paraurethral glands. Including the authors' six specimens, 46 specimens have been reported in the available English literature. The accumulated experience confirms the initial impression that these tumors develop predominantly in the urethras of women and occur over a wide age range. Despite high stage at diagnosis, most patients have been alive with no evidence of disease when reported, a prognosis that seems to apply regardless of length of follow-up.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600038     DOI: 10.1016/s0046-8177(96)90064-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival.

Authors:  Joris W Derksen; Otto Visser; Guy Brutel de la Rivière; Eric J Meuleman; Eddi A Heldeweg; Brunolf W Lagerveld
Journal:  World J Urol       Date:  2012-05-22       Impact factor: 4.226

2.  Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.

Authors:  Rohit Mehra; Pankaj Vats; Shanker Kalyana-Sundaram; Aaron M Udager; Michael Roh; Ajjai Alva; Jincheng Pan; Robert J Lonigro; Javed Siddiqui; Alon Weizer; Cheryl Lee; Xuhong Cao; Yi-Mi Wu; Dan R Robinson; Saravana M Dhanasekaran; Arul M Chinnaiyan
Journal:  Am J Pathol       Date:  2014-01-03       Impact factor: 4.307

Review 3.  Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review.

Authors:  Ji Lu; Zhihui Xu; Fengming Jiang; Yan Wang; Yuchuan Hou; Chunxi Wang; Qihui Chen
Journal:  World J Surg Oncol       Date:  2012-02-10       Impact factor: 2.754

Review 4.  Adenocarcinoma of the urinary bladder.

Authors:  Vipulkumar Dadhania; Bogdan Czerniak; Charles C Guo
Journal:  Am J Clin Exp Urol       Date:  2015-08-08

5.  Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems.

Authors:  Borislav A Alexiev; Fabio Tavora
Journal:  Virchows Arch       Date:  2013-01-11       Impact factor: 4.064

6.  Clear cell adenocarcinoma of a female urethra: A case report and review of the literature.

Authors:  Amel Trabelsi; Soumaya Ben Abdelkrim; Soumaya Rammeh; Wided Stita; Nabil Ben Sorba; Moncef Mokni; Slim Ben Ahmed; Sadok Korbi
Journal:  N Am J Med Sci       Date:  2009-11

7.  Clear cell adenocarcinoma of the renal pelvis in a male patient.

Authors:  Sarawut Kongkarnka; Pruit Kitirattakarn; Hironori Katayama; Surapan Khunamornpong
Journal:  Case Rep Pathol       Date:  2013-12-23

Review 8.  Clear cell adenocarcinoma of the urethra: review of the literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int J Surg Oncol       Date:  2015-01-20

9.  Cytologic findings of clear cell adenocarcinoma of the urethra: a case report.

Authors:  Jee-Young Han; Kyu-Ho Kim; Lucia Kim; Suk-Jin Choi; In-Suh Park; Joon-Mee Kim; Young-Chae Chu; Sang-Min Yoon
Journal:  Korean J Pathol       Date:  2012-04-25

10.  Primary clear cell adenocarcinoma of the colon presenting as a huge extracolic mass: A case report.

Authors:  Weiwei Wang; Xuehua Li; Guimei Qu; Tiangang Leng; Junzu Geng
Journal:  Oncol Lett       Date:  2014-08-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.